Microlife OXY200 Manual Del Usuario página 8

Should guarantee service be required, please contact the
dealer from where the product was purchased, or your local
Microlife service. You may contact your local Microlife
service through our website: www.microlife.com/support
Compensation is limited to the value of the product. The
guarantee will be granted if the complete product is
returned with the original invoice. Repair or replacement
within guarantee does not prolong or renew the guarantee
period. The legal claims and rights of consumers are not
limited by this guarantee.
11. Technical specifications
Model: Pulse Oximeter JPD-510E
Type: OXY 200
Display: LED display
Software version: V 2.12
SpO
2
Measurement range:
35 ~ 100%
Measurement
≤3% (70% – 100%)
precision:
Resolution: 1%
Pulse rate
6
Measurement range:
25 ~ 250 bpm
Accuracy: ±2 bpm
Resolution: 1 bpm
Operating 5 – 40 °C / 41 – 104 °F
conditions:
15 – 80% relative maximum
humidity
Storage conditions: -10 – +50°C / 14 – 122 °F
10 – 93% relative maximum
humidity
Automatic switch-off:
Automatically shut down in 10
seconds, when no or low signal
is detected.
Battery: 2 x 1.5 V alkaline batteries; size
AAA
Battery lifetime: approx. 30 hours (using new
batteries)
Weight: 50 g (including batteries)
Dimensions:
58 x 32 x 34 mm
IP Class: IP22
Reference to
EN ISO10993-1/-5/-10; IEC
standards: 60601-1; EN 60601-1-2; ISO
80601-2-61;
EN 62304; EN 60601-1-6
Expected service life:
5 years (when used 15 times/
day; 20 minutes for each
measurement)
Technical alterations reserved.
Note 1: The fingertip pulse oximeter measurements are
statistically distributed, only about two-thirds of pulse oxim-
eter equipment measurements can be expected to fall
within ±2% A (Average-root-mean-square-error) of the
rmse
value measured by a co-oximeter.
Note 2: The statistic conclusion of a controlled desaturation
study which is guided by «ISO 80601-2-61, Annex EE, guide-
line for evaluating and documenting SpO2 accuracy in human
subjects». The statistic result displayed the accuracy distribu-
tion between the range of 70% – 100%, which is 2.83%.
Any serious incident that has occurred in relation to the
device shall be reported to the manufacturer and the
competent authority of the Member State in which the user
and / or the patient is established.
The device is a Class IIa medical device.
Device complies with European Regulation on medical
devices EU MDR 2017/745.